scispace - formally typeset
M

Michael Scharl

Researcher at University of Zurich

Publications -  265
Citations -  17364

Michael Scharl is an academic researcher from University of Zurich. The author has contributed to research in topics: Inflammatory bowel disease & Medicine. The author has an hindex of 37, co-authored 228 publications receiving 13160 citations. Previous affiliations of Michael Scharl include University of Lausanne.

Papers
More filters
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

Daniel J. Klionsky, +2522 more
- 21 Jan 2016 - 
TL;DR: In this paper, the authors present a set of guidelines for the selection and interpretation of methods for use by investigators who aim to examine macro-autophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes.
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy

Daniel J. Klionsky, +1287 more
- 01 Apr 2012 - 
TL;DR: These guidelines are presented for the selection and interpretation of methods for use by investigators who aim to examine macroautophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes.
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)

Daniel J. Klionsky, +2983 more
- 08 Feb 2021 - 
TL;DR: In this article, the authors present a set of guidelines for investigators to select and interpret methods to examine autophagy and related processes, and for reviewers to provide realistic and reasonable critiques of reports that are focused on these processes.
Journal ArticleDOI

Extraintestinal manifestations of inflammatory bowel disease

Stephan R. Vavricka, +5 more
- 01 Aug 2015 - 
TL;DR: Extraintestinal manifestations in inflammatory bowel disease (IBD) are frequent and may occur before or after IBD diagnosis, and successful therapy of EIM is essential for improving quality of life of patients with IBD.
Journal ArticleDOI

Smoking Cessation Induces Profound Changes in the Composition of the Intestinal Microbiota in Humans

Luc Biedermann, +15 more
- 14 Mar 2013 - 
TL;DR: The results indicate that smoking is an environmental factor modulating the composition of human gut microbiota, suggesting a potential pathogenetic link between weight gain and smoking cessation and giving rise to a potential association of smoking status and the course of IBD.